EB
Estuary Biotherapeutics, Inc.
SEC filingBiotechnology · Menlo Park, CA
Amount raised$40.7Msold at filing
Total offering$103.7M$63M still open
Investors in the raise25count reported to the SEC
FiledOct 16, 2026first sale Jul 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Wayne E. SackettExecutive Officer, Director
Jacob BauerDirector
Owen SmithDirector
Emily MinkowDirector
Executive officers, directors and promoters as listed on the Form D.